Hereditary Cerebellar Ataxia

Stem cells from cord blood are being investigated as a possible treatment for cerebral ataxia. Click on the link provided to find out more about the trial. It remains too early to know if this approach will be suitable. We need evidence collected in clinical trials to determine if a proposed stem cell treatment is both safe and effective.

tagged as Hereditary Cerebellar Ataxia

  • A New Method to Treat Hereditary Cerebellar Ataxia — Umbilical Cord Mesenchymal Stem Cells Transplantation Location: China
    Overview: The aim of this study is to investigate whether stem cells from donated umbilical cord blood can improve the degenerative effects of Hereditary Cerebellar Ataxia, an inherited genetic disease affecting speech and motor function. In this study the progress of two groups of 10 patients will be compared. The first group (the interventional group) will receive a transplant of donated umbilical cord blood. The second group (control group) will receive conventional therapy only. The study commenced in September 2012 and is being conducted at the Chinese Armed Police General Hospital in Beijing.
    Link to Clinical Registry
    Trial Design: Safety and Efficacy Study
    Status: Open - Recruiting
    Stem Cell: Umbilical Cord Stem Cells